1. Home
  2. NSPR vs TYGO Comparison

NSPR vs TYGO Comparison

Compare NSPR & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • TYGO
  • Stock Information
  • Founded
  • NSPR 2005
  • TYGO 2007
  • Country
  • NSPR United States
  • TYGO United States
  • Employees
  • NSPR N/A
  • TYGO N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • TYGO Semiconductors
  • Sector
  • NSPR Health Care
  • TYGO Technology
  • Exchange
  • NSPR Nasdaq
  • TYGO Nasdaq
  • Market Cap
  • NSPR 75.1M
  • TYGO 60.2M
  • IPO Year
  • NSPR N/A
  • TYGO N/A
  • Fundamental
  • Price
  • NSPR $2.44
  • TYGO $1.27
  • Analyst Decision
  • NSPR Strong Buy
  • TYGO Strong Buy
  • Analyst Count
  • NSPR 2
  • TYGO 2
  • Target Price
  • NSPR $4.50
  • TYGO $3.75
  • AVG Volume (30 Days)
  • NSPR 44.5K
  • TYGO 33.9K
  • Earning Date
  • NSPR 08-05-2025
  • TYGO 08-05-2025
  • Dividend Yield
  • NSPR N/A
  • TYGO N/A
  • EPS Growth
  • NSPR N/A
  • TYGO N/A
  • EPS
  • NSPR N/A
  • TYGO N/A
  • Revenue
  • NSPR $7,027,000.00
  • TYGO $63,051,000.00
  • Revenue This Year
  • NSPR $27.41
  • TYGO $69.44
  • Revenue Next Year
  • NSPR $127.08
  • TYGO $21.75
  • P/E Ratio
  • NSPR N/A
  • TYGO N/A
  • Revenue Growth
  • NSPR 8.49
  • TYGO N/A
  • 52 Week Low
  • NSPR $2.07
  • TYGO $0.58
  • 52 Week High
  • NSPR $3.80
  • TYGO $1.85
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 50.84
  • TYGO 71.38
  • Support Level
  • NSPR $2.40
  • TYGO $1.13
  • Resistance Level
  • NSPR $2.59
  • TYGO $1.26
  • Average True Range (ATR)
  • NSPR 0.11
  • TYGO 0.08
  • MACD
  • NSPR 0.00
  • TYGO 0.01
  • Stochastic Oscillator
  • NSPR 57.50
  • TYGO 87.50

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About TYGO Tigo Energy Inc.

Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.

Share on Social Networks: